20030106
 Some CryoLife Tissue Is Freed of FDA Rules Limiting Distribution   The Wall Street Journal,  Jan 7, 2003  The FDA halted CryoLife's human-tissue processing in August and issued a recall after linking the company's orthopedic tissue to a patient's death in 2001. In addition to allowing the limited distribution of the nonvalved cardiac and vascular tissue, the September agreement permitted the company to sell nonvalved heart parts, veins and arteries when patients had no medical alternative.   
